Opportunity Information: Apply for RFA DA 10 006
Apply for RFA DA 10 006
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Dec 9, 2009 and posted on Dec 9, 2009.
- Applicants must submit their applications by Apr 7, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Eligible applicants include: For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Special district governments State governments City or township governments Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R01)" (Funding Opportunity Number RFA-DA-10-006) is a National Institutes of Health program led by NIDA that targets a specific gap in substance use disorder (SUD) care: many people with SUDs experience cognitive changes that can make it harder to benefit from treatment, stay engaged, learn new coping skills, or maintain recovery. The core aim of the announcement is to support clinical research projects that either design new or further develop existing cognitive remediation strategies and test whether those strategies can strengthen outcomes of drug abuse treatment. In practical terms, the focus is on interventions that address cognitive functions relevant to treatment success (for example, attention, memory, executive functioning, decision-making, inhibitory control, learning, and related skills) with the expectation that improving these functions will translate into better treatment adherence, retention, and overall recovery-related outcomes.
This opportunity uses the NIH R01 mechanism, which is intended for well-developed, hypothesis-driven research projects with a scope and level of evidence appropriate for a full research project grant. It is explicitly paired with a parallel funding announcement of the same scientific scope that uses the R21 mechanism (RFA-DA-10-007). That parallel structure typically means applicants should choose the mechanism that best matches the maturity of their proposed work: the R01 route for more established projects that are ready for a fuller clinical research plan, and the R21 route for earlier-stage, exploratory, or high-risk/high-reward development work.
NIDA anticipated committing about $3,000,000 in total costs (meaning direct costs plus facilities and administrative costs) in FY 2010 across this R01 announcement and the parallel R21 announcement combined, with an expectation of funding roughly 5 to 6 new awards in total. The program is categorized as discretionary grant funding within the health and education activity area, and it falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The announcement states there is no cost sharing or matching requirement, which matters for budgeting because applicants are not required to provide non-federal matching funds as a condition of receiving an award.
Eligibility is broad and includes a wide range of organizational types across the public, private, nonprofit, and governmental spectrum. Eligible applicants include small businesses and other for-profit organizations (other than small businesses), nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those specific nonprofit categories), public housing authorities, independent school districts, and multiple levels of government including state, county, and city/township governments as well as special district governments. Institutions of higher education are eligible in both public/state-controlled and private categories. The eligibility list also explicitly extends to entities such as federally recognized tribal governments and other tribal organizations, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, historically Black colleges and universities (HBCUs), faith-based or community-based organizations, U.S. territories or possessions, regional organizations, eligible federal agencies, and even non-U.S. (foreign) organizations. That breadth signals an intent to attract multidisciplinary teams and diverse clinical settings capable of conducting rigorous clinical research tied to real-world SUD treatment.
Key administrative details include a posted and created date of December 9, 2009, with an original and current closing date of April 7, 2010, and an archive date of May 8, 2010. The full announcement was hosted through the NIH grants guide (link provided in the source), and NIH Office of Extramural Research contact information was included for technical access issues. Overall, the opportunity is best understood as an NIH/NIDA investment in clinically grounded cognitive remediation approaches that can be integrated with, or used to augment, substance use disorder treatments in order to improve measurable patient outcomes.
Frequently Asked Questions (FAQ)
What is the name of this grant opportunity?
The opportunity is titled "Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R01)."
What is the Funding Opportunity Number?
The Funding Opportunity Number is RFA-DA-10-006.
Which federal agency is leading this funding opportunity?
This is a National Institutes of Health (NIH) program led by the National Institute on Drug Abuse (NIDA).
What problem or gap is this grant trying to address?
The opportunity targets a gap in substance use disorder (SUD) care: many people with SUDs experience cognitive changes that can make it harder to benefit from treatment. These cognitive changes may interfere with staying engaged in treatment, learning coping skills, and maintaining recovery.
What is the main purpose of the funded research?
The core aim is to support clinical research projects that design new or further develop existing cognitive remediation strategies and test whether those strategies can improve outcomes of drug abuse treatment.
What types of interventions are in scope?
Interventions should address cognitive functions relevant to treatment success, with the expectation that improving those functions will translate into better treatment adherence, retention, and overall recovery-related outcomes.
What cognitive functions does the announcement emphasize?
The announcement highlights cognitive functions such as attention, memory, executive functioning, decision-making, inhibitory control, learning, and related skills.
Does the opportunity require clinical research?
Yes. The announcement specifically supports clinical research projects that test cognitive remediation approaches in ways tied to drug abuse treatment outcomes.
What NIH grant mechanism does this opportunity use?
This funding opportunity uses the NIH R01 mechanism.
What does the R01 mechanism imply about the type of project expected?
The R01 mechanism is intended for well-developed, hypothesis-driven research projects with a scope and level of evidence appropriate for a full research project grant.
Is there a related or parallel funding opportunity?
Yes. The R01 announcement is explicitly paired with a parallel funding announcement with the same scientific scope that uses the R21 mechanism (RFA-DA-10-007).
How should an applicant decide between the R01 and the parallel R21?
Based on the information provided, the R01 route is positioned for more established projects ready for a fuller clinical research plan, while the R21 route is positioned for earlier-stage, exploratory, or high-risk/high-reward development work.
How much total funding did NIDA anticipate committing?
NIDA anticipated committing about $3,000,000 in total costs in FY 2010 across this R01 announcement and the parallel R21 announcement combined.
What does "total costs" mean in this context?
"Total costs" means direct costs plus facilities and administrative (F&A) costs.
How many awards were expected to be funded?
The program expected to fund roughly 5 to 6 new awards in total across the R01 and the parallel R21 announcements combined.
Is this a discretionary grant program?
Yes. The program is categorized as discretionary grant funding.
What activity area is this opportunity associated with?
It is described as falling within the health and education activity area.
What is the CFDA number for this program?
The opportunity falls under CFDA 93.279 (Drug Abuse and Addiction Research Programs).
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement, meaning applicants are not required to provide non-federal matching funds as a condition of receiving an award.
Who is eligible to apply?
Eligibility is broad and includes organizations across the public, private, nonprofit, and governmental spectrum, including U.S. and non-U.S. (foreign) organizations.
Are small businesses eligible?
Yes. Small businesses are listed as eligible applicants.
Are for-profit organizations eligible?
Yes. The eligibility list includes for-profit organizations (other than small businesses) as well as small businesses.
Are nonprofit organizations eligible?
Yes. The eligibility list includes nonprofits with 501(c)(3) status and nonprofits without 501(c)(3) status, as described in the opportunity.
Are institutions of higher education eligible?
Yes. Institutions of higher education are eligible in both public/state-controlled and private categories.
Are public housing authorities eligible?
Yes. Public housing authorities are listed as eligible applicants.
Are independent school districts eligible?
Yes. Independent school districts are listed as eligible applicants.
Which levels of government are eligible to apply?
Eligible government applicants include state, county, and city/township governments, as well as special district governments.
Are tribal governments and tribal organizations eligible?
Yes. Federally recognized tribal governments and other tribal organizations are explicitly included as eligible applicants.
Are tribally controlled colleges and universities (TCCUs) eligible?
Yes. Tribally Controlled Colleges and Universities (TCCUs) are listed as eligible.
Are minority-serving institutions included in eligibility?
Yes. The eligibility list explicitly includes Alaska Native and Native Hawaiian Serving Institutions, Hispanic-serving institutions, and historically Black colleges and universities (HBCUs).
Are faith-based or community-based organizations eligible?
Yes. Faith-based or community-based organizations are included in the eligibility list.
Are U.S. territories or possessions eligible?
Yes. U.S. territories or possessions are listed among eligible applicants.
Are regional organizations eligible?
Yes. Regional organizations are included in the eligibility list.
Are federal agencies eligible to apply?
Yes. Eligible federal agencies are included in the eligibility list.
Are non-U.S. (foreign) organizations eligible to apply?
Yes. The eligibility list explicitly includes non-U.S. (foreign) organizations.
When was this funding opportunity posted?
The posted date (and created date) is December 9, 2009.
What was the application closing date?
The original and current closing date listed is April 7, 2010.
When was the opportunity archived?
The archive date is May 8, 2010.
Where was the full announcement published?
The full announcement was hosted through the NIH grants guide (a link was provided in the source information).
Who should be contacted for technical access issues?
NIH Office of Extramural Research contact information was included for technical access issues.
What kinds of outcomes is NIDA aiming to improve through these projects?
The opportunity emphasizes improving measurable drug abuse treatment outcomes, including treatment adherence, retention, and overall recovery-related outcomes, by strengthening cognitive functions relevant to treatment success.
How is this opportunity best summarized?
It is an NIH/NIDA investment in clinically grounded cognitive remediation approaches that can be integrated with, or used to augment, substance use disorder treatments to improve patient outcomes.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R21)
Previous opportunity: Systems Biology Approach to the Mechanisms of TB Latency and Reactivation (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 10 006
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 10 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cognitive Remediation Approaches to Improve Drug Abuse Treatment Outcomes (R21) Apply for RFA DA 10 007 Funding Number: RFA DA 10 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Academic Career Award (Parent K07) Apply for PA 10 058 Funding Number: PA 10 058 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pre Application for the 2010 NIDA Avant Garde Award Program for HIV/AIDS Research (X02) Apply for PAR 10 068 Funding Number: PAR 10 068 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| 2010 NIDA Avant Garde Award Program for HIV/AIDS Research (DP1) Apply for RFA DA 10 012 Funding Number: RFA DA 10 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| AIDS Malignancy Clinical Trials Consortium (Limited Competition U01) Apply for RFA CA 10 502 Funding Number: RFA CA 10 502 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mechanism for Time Sensitive Drug Abuse Research (R01) Apply for PAR 10 072 Funding Number: PAR 10 072 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, and Prognostics toward Commercialization (R44) Apply for RFA CA 10 009 Funding Number: RFA CA 10 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Image Guided Cancer Interventions (SBIR R43/R44) Apply for PA 10 079 Funding Number: PA 10 079 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Image Guided Cancer Interventions (STTR R41/R42) Apply for PA 10 080 Funding Number: PA 10 080 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Shared Instrumentation Grant Program (S10) Apply for PAR 10 082 Funding Number: PAR 10 082 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Systems Biology, HIV/AIDS, and Substance Abuse (R01) Apply for RFA DA 10 014 Funding Number: RFA DA 10 014 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| Pre Application for the 2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (X02) Apply for PAR 10 095 Funding Number: PAR 10 095 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| 2010 NIDA Translational Avant Garde Award for Medication Development for Diseases of Addiction (DP1) Apply for RFA DA 10 013 Funding Number: RFA DA 10 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for Substance Related Disorders (R01) Apply for RFA DA 10 018 Funding Number: RFA DA 10 018 Agency: National Institutes of Health Category: Education Health Funding Amount: $1,000,000 |
| Deep Sequencing and Analysis of Pharmacogenomic Regions Discovery and Analysis of Genetic Variants Contributing to Drug Abuse and Addiction (R01) Apply for RFA DA 10 019 Funding Number: RFA DA 10 019 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Institutional Clinical and Translational Science Award (U54) Apply for RFA RM 10 001 Funding Number: RFA RM 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R01) Apply for PAS 10 097 Funding Number: PAS 10 097 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Technology Based Adherence Interventions for Substance Abusing Populations with HIV (R34) Apply for PAS 10 098 Funding Number: PAS 10 098 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R01) Apply for RFA NR 10 001 Funding Number: RFA NR 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Chronic Co Morbid Conditions in HIV U.S. Adults on Highly Effective Anti Retroviral Therapy (R21) Apply for RFA NR 10 002 Funding Number: RFA NR 10 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 10 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.